- Published at
- by investing.com
mixed
mixed
Monte Rosa Therapeutics announces key leadership promotions By Investing.com
Monte Rosa Therapeutics announces key leadership promotions
News for Momenta Pharmaceuticals, Inc. (MNTA)
- Published at
- by prnewswire.com
mixedmixed- Published at
- by marketscreener.com
mixedmixedCue Biopharma Welcomes Industry Veteran Mr. Patrick Verheyen to its Board of Directors
BOSTON, April 12, 2023 -- Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific... | April 12, 2023- Published at
- by globenewswire.com
mixedmixedCue Biopharma Welcomes Industry Veteran Mr. Patrick Verheyen to its Board of Directors
BOSTON, April 12, 2023 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of...- Published at
- by prnewswire.com
mixedmixedAntinuclear Antibody Testing Market Predicted to Gather $4,999.40 Million and Grow at 14.97% CAGR in the 2022-2031 Analysis Timeframe [300-Pages] | Explained by Research Dive
/PRNewswire/ -- Research Dive has added a new report to its offering titled, "Antinuclear Antibody Test Market, by Product (Reagents & Assay Kits, Systems and...- Published at
- by globenewswire.com
mixedmixedFulcrum Therapeutics Appoints Chief Medical Officer and Chief Scientific Officer
— Santiago Arroyo, M.D., Ph.D. joined as CMO on November 7, 2022 — — Jeff W. Jacobs, Ph.D. to join as CSO on December 1, 2022 — CAMBRIDGE, Mass. –, Nov. ...- Published at
- by seekingalpha.com
mixedmixedImmunovant Stock: Capitalizing On Fast Growing FcRn Space With Novel Asset (NASDAQ:IMVT)
Shares have lost roughly half their value since arriving on the Nasdaq in late 2019 via SPAC. See why IMVT is a Buy and I suggest initiating a pilot position in the near term.- Published at
- by prnewswire.com
positivepositiveFDA Awards $1.3 Million Grant to Biologics & Biosimilars Collective Intelligence Consortium
/PRNewswire/ -- The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) announced today that it has received a major grant from the Food & Drug...- Published at
- by marketscreener.com
mixedmixedReWalk Robotics Appoints Michael Lawless as Chief Financial Officer
Brings Significant Experience in M&A, Investor Relations, and Financial StrategyMARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Sept. 08, 2022 -- ReWalk Robotics... | September 8, 2022- Published at
- by financialpost.com
mixedmixedTakeda Delivers Strong First Quarter FY2022 Results; On Track Towards Full-Year Management Guidance
Q1 FY2022 Results Demonstrate a Strong Start to the Year with Core Revenue Growth at Constant Exchange Rate (CER) of +8.3% (Reported Revenue +2.4%) Growth…- Published at
- by prnewswire.com
mixedmixedNeuroimmunology Drugs Market worth $37.32 billion by 2030 - Exclusive Report by InsightAce Analytic
/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Global Neuroimmunology Drugs Market By Indication...- Published at
- by benzinga.com
mixedmixedGlobal Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report 2020: COVID-19 Growth and Change - Market is Expected to Recover in 2023 - Forecast to 2030
Dublin, Feb. 09, 2021 (GLOBE NEWSWIRE) -- The "Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Report 2020-30: COVID-19 Growth and ...